---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-24-000562"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:46:12.016546+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Electromed Q1 FY2025 revenue up 19% to $14.7M; net income $1.5M vs $0.2M YoY

## Summary
- Diluted EPS $0.16 vs $0.02 prior year; operating income $1.9M (13.2% rev) vs $0.1M.
- Gross margin improved to 78.3% from 77.1%; direct homecare revenue rose 18.5% to $13.2M.
- Repurchased 262,756 shares for ~$4.5M at avg $17.26; $0.5M remaining on $5M authorization.
- Direct sales force of 53 reps; hired VP Marketing Peter Horwich; launched Triple Down on Bronchiectasis campaign.
- Cash $13.9M, no debt; annualized homecare revenue per rep $985,000 (within $900k-$1M target).

## SEC filing metadata
- accession: 0000897101-24-000562
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/0000897101-24-000562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/elmd241175_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-24-000562
- JSON: https://secwatch.observer/filing/0000897101-24-000562.json
- Plain text: https://secwatch.observer/filing/0000897101-24-000562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.